Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

EPHX1 polymorphisms, COPD and asthma in 47,000 individuals and in meta-analysis.

Lee J, Nordestgaard BG, Dahl M.

Eur Respir J. 2011 Jan;37(1):18-25. doi: 10.1183/09031936.00012110. Epub 2010 Jun 1.

2.

Analyses of association between PPAR gamma and EPHX1 polymorphisms and susceptibility to COPD in a Hungarian cohort, a case-control study.

Penyige A, Poliska S, Csanky E, Scholtz B, Dezso B, Schmelczer I, Kilty I, Takacs L, Nagy L.

BMC Med Genet. 2010 Nov 2;11:152. doi: 10.1186/1471-2350-11-152.

3.

Surfactant protein B polymorphisms, pulmonary function and COPD in 10,231 individuals.

Bækvad-Hansen M, Nordestgaard BG, Dahl M.

Eur Respir J. 2011 Apr;37(4):791-9. doi: 10.1183/09031936.00026410. Epub 2010 Aug 6.

4.

Genetic variants of microsomal epoxide hydrolase and glutamate-cysteine ligase in COPD.

Chappell S, Daly L, Morgan K, Guetta-Baranes T, Roca J, Rabinovich R, Lotya J, Millar AB, Donnelly SC, Keatings V, MacNee W, Stolk J, Hiemstra PS, Miniati M, Monti S, O'Connor CM, Kalsheker N.

Eur Respir J. 2008 Oct;32(4):931-7. doi: 10.1183/09031936.00065308. Epub 2008 Jul 9.

5.

Genetic and biochemical markers of obstructive lung disease in the general population.

Dahl M.

Clin Respir J. 2009 Apr;3(2):121-2. doi: 10.1111/j.1752-699X.2008.00110.x.

PMID:
20298391
6.
7.

Microsomal epoxide hydrolase is not associated with COPD in a community-based sample.

Matheson MC, Raven J, Walters EH, Abramson MJ, Ellis JA.

Hum Biol. 2006 Dec;78(6):705-17.

PMID:
17564249
8.

Association between polymorphisms of microsomal epoxide hydrolase and COPD: results from meta-analyses.

Hu G, Shi Z, Hu J, Zou G, Peng G, Ran P.

Respirology. 2008 Nov;13(6):837-50. doi: 10.1111/j.1440-1843.2008.01356.x. Review.

PMID:
18811882
9.

Genetic polymorphism of epoxide hydrolase and glutathione S-transferase in COPD.

Cheng SL, Yu CJ, Chen CJ, Yang PC.

Eur Respir J. 2004 Jun;23(6):818-24.

10.
11.

β2-adrenergic receptor polymorphisms, asthma and COPD: two large population-based studies.

Thomsen M, Nordestgaard BG, Sethi AA, Tybjærg-Hansen A, Dahl M.

Eur Respir J. 2012 Mar;39(3):558-66. doi: 10.1183/09031936.00023511. Epub 2011 Nov 10.

12.

Genetic association between COPD and polymorphisms in TNF, ADRB2 and EPHX1.

Brøgger J, Steen VM, Eiken HG, Gulsvik A, Bakke P.

Eur Respir J. 2006 Apr;27(4):682-8.

13.

Effect of N-acetylcysteine in COPD patients with different microsomal epoxide hydrolase genotypes.

Zhang JQ, Zhang JQ, Liu H, Zhao ZH, Fang LZ, Liu L, Fu WP, Shu JK, Feng JG, Dai LM.

Int J Chron Obstruct Pulmon Dis. 2015 May 13;10:917-23. doi: 10.2147/COPD.S79710. eCollection 2015.

14.

Microsomal epoxide hydrolase gene polymorphisms and susceptibility to chronic obstructive pulmonary disease in the Tunisian population.

Lakhdar R, Denden S, Knani J, Leban N, Daimi H, Hassine M, Lefranc G, Chibani JB, Khelil AH.

Genet Test Mol Biomarkers. 2010 Dec;14(6):857-63. doi: 10.1089/gtmb.2009.0168. Epub 2010 Oct 9.

PMID:
20932192
15.

[Association between polymorphisms in the microsomal epoxide hydrolase (mEH) gene and chronic obstructive pulmonary disease].

Xiao D, Wang C, Du MJ, Pang BS, Zhang HY, Xiao B, Liu JZ, Weng XZ, Su L, Christiani DC.

Zhonghua Yi Xue Za Zhi. 2003 Oct 25;83(20):1782-6. Chinese.

PMID:
14642084
16.

Relationship between polymorphisms of genes encoding microsomal epoxide hydrolase and glutathione S-transferase P1 and chronic obstructive pulmonary disease.

Xiao D, Wang C, Du MJ, Pang BS, Zhang HY, Xiao B, Liu JZ, Weng XZ, Su L, Christiani DC.

Chin Med J (Engl). 2004 May;117(5):661-7.

PMID:
15161530
17.

Asthma and COPD in cystic fibrosis intron-8 5T carriers. A population-based study.

Dahl M, Tybjaerg-Hansen A, Lange P, Nordestgaard BG.

Respir Res. 2005 Oct 9;6:113.

18.

Surfactant protein-B 121ins2 heterozygosity, reduced pulmonary function, and chronic obstructive pulmonary disease in smokers.

Baekvad-Hansen M, Dahl M, Tybjaerg-Hansen A, Nordestgaard BG.

Am J Respir Crit Care Med. 2010 Jan 1;181(1):17-20. doi: 10.1164/rccm.200906-0963OC. Epub 2009 Oct 15.

PMID:
19833825
19.

Genetically increased antioxidative protection and decreased chronic obstructive pulmonary disease.

Juul K, Tybjaerg-Hansen A, Marklund S, Lange P, Nordestgaard BG.

Am J Respir Crit Care Med. 2006 Apr 15;173(8):858-64. Epub 2006 Jan 6.

PMID:
16399992
20.

CHRNA3 genotype, nicotine dependence, lung function and disease in the general population.

Kaur-Knudsen D, Nordestgaard BG, Bojesen SE.

Eur Respir J. 2012 Dec;40(6):1538-44. doi: 10.1183/09031936.00176811. Epub 2012 Mar 22.

Supplemental Content

Support Center